Romania's Antibiotice Iasi inaugurates 2.5 MW photovoltaic facility
Antibiotice Iasi has inaugurated a 2.5 MW photovoltaic facility, a project funded by the Romanian Recovery and Resilience Plan (RRP).
Antibiotice Iasi has inaugurated a 2.5 MW photovoltaic facility, a project funded by the Romanian Recovery and Resilience Plan (RRP).
Antibiotice Iași Company, a pharmaceutical manufacturer with Romanian capital, became a member of the Sustainable Romania Coalition, the first platform for sustainable development established by the Embassy of Sustainability in Romania (ASR).
The state-owned drug manufacturer Antibiotice Iași made total investments worth RON 27.17 million (€5.4 million) in the first six months of the year for sustainable development.
Antibiotice Iaşi Company, the largest Romanian producer of generic drugs, will build a 2.5 MW photovoltaic plant. The company announced that it obtained from the Ministry of Investments and European Projects financing of RON4.08 million (€816,000) in this regard.
A significant portion of EU grants is allocated to support sustainable initiatives, further driving the rise in these types of loans.
Polish energy group Orlen announced that its subsidiary, Energa Operator, has secured a €1.8bn loan to modernize the power grid, preparing it for the integration of renewable energy sources.
OMV Petrom announced the commencement of construction for a production unit dedicated to sustainable aviation fuel (SAF) and renewable diesel (HVO) at the Petrobrazi refinery.
The European Investment Bank (EIB) is providing a €240 million loan to Slovakia for co-funding of EU-supported green and digital projects across the country.
In line with its 2030 ambition to decarbonize the hydrogen used in its European refineries, TotalEnergies has signed agreements with Air Liquide to develop two projects in the Netherlands.